Your browser is no longer supported. Please, upgrade your browser.
Settings
EBS [NYSE]
Emergent BioSolutions Inc.
Index- P/E31.24 EPS (ttm)3.11 Insider Own2.70% Shs Outstand53.00M Perf Week-17.01%
Market Cap5.85B Forward P/E17.70 EPS next Y5.49 Insider Trans-15.66% Shs Float45.20M Perf Month-11.17%
Income166.60M PEG3.40 EPS next Q1.73 Inst Own87.10% Short Float5.30% Perf Quarter21.94%
Sales1.33B P/S4.39 EPS this Y-8.50% Inst Trans4.03% Short Ratio4.17 Perf Half Y-21.39%
Book/sh23.61 P/B4.11 EPS next Y-40.45% ROA7.00% Target Price113.00 Perf Year66.30%
Cash/sh6.89 P/C14.09 EPS next 5Y9.20% ROE14.80% 52W Range46.37 - 137.61 Perf YTD8.43%
Dividend- P/FCF30.15 EPS past 5Y-2.60% ROI4.80% 52W High-29.40% Beta1.20
Dividend %- Quick Ratio2.30 Sales past 5Y22.30% Gross Margin64.40% 52W Low109.51% ATR5.87
Employees1834 Current Ratio3.20 Sales Q/Q23.50% Oper. Margin19.70% RSI (14)37.57 Volatility5.57% 4.72%
OptionableYes Debt/Eq0.70 EPS Q/Q-11.90% Profit Margin12.80% Rel Volume0.89 Prev Close98.80
ShortableYes LT Debt/Eq0.68 EarningsFeb 18 AMC Payout0.00% Avg Volume573.98K Price97.15
Recom2.00 SMA20-14.59% SMA50-6.87% SMA200-0.58% Volume508,775 Change-1.67%
Feb-24-21Upgrade Chardan Capital Markets Neutral → Buy $112
Feb-19-21Downgrade Chardan Capital Markets Buy → Neutral $112
Jan-08-21Downgrade Wells Fargo Overweight → Equal Weight $110
Sep-14-20Resumed JP Morgan Neutral $103
Jul-31-20Reiterated Chardan Capital Markets Buy $86 → $112
Sep-12-19Initiated Guggenheim Buy
Sep-04-19Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18Upgrade Goldman Neutral → Buy
Aug-03-18Reiterated Chardan Capital Markets Buy $53 → $57
Jun-13-18Initiated Argus Buy $62
Apr-25-18Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18Initiated Goldman Neutral
Jan-16-18Reiterated Chardan Capital Markets Buy $47 → $53
Jun-28-16Reiterated Singular Research Buy $44 → $40
Apr-15-16Initiated Chardan Capital Markets Buy $47
Mar-28-16Initiated Singular Research Buy $44
Feb-19-16Initiated Wells Fargo Outperform
May-15-14Initiated Summer Street Research Buy $35
May-31-11Reiterated WBB Securities Strong Buy $20.50 → $30
Jan-10-11Reiterated Wedbush Outperform $27 → $32
Feb-25-21 07:00AM  
Feb-24-21 10:07AM  
Feb-19-21 11:27AM  
10:57AM  
04:01AM  
Feb-18-21 04:45PM  
04:38PM  
04:25PM  
04:05PM  
03:15PM  
Feb-17-21 12:44PM  
Feb-15-21 12:00AM  
Feb-11-21 06:14AM  
Feb-10-21 01:40PM  
Feb-04-21 02:37PM  
01:54PM  
06:30AM  
Feb-03-21 12:08PM  
Feb-01-21 02:57PM  
01:45PM  
Jan-27-21 01:06PM  
12:45PM  
Jan-26-21 03:39PM  
Jan-25-21 02:20PM  
01:21PM  
08:30AM  
Jan-20-21 12:45PM  
Jan-13-21 01:38PM  
Jan-12-21 10:37AM  
Jan-11-21 09:22AM  
09:15AM  
Jan-10-21 02:00PM  
Jan-07-21 12:45PM  
Jan-06-21 05:50PM  
11:30AM  
Jan-05-21 07:03AM  
Jan-04-21 03:25PM  
06:30AM  
Dec-31-20 09:40AM  
Dec-30-20 11:21AM  
Dec-29-20 04:05PM  
Dec-18-20 08:15PM  
Dec-17-20 09:19AM  
Dec-16-20 11:56PM  
Dec-15-20 09:38AM  
Dec-05-20 11:32AM  
Dec-02-20 12:35PM  
Nov-27-20 06:14AM  
Nov-18-20 09:30AM  
Nov-10-20 09:40AM  
Nov-09-20 10:18AM  
08:58AM  
Nov-06-20 06:50PM  
11:16AM  
10:57AM  
10:54AM  
10:52AM  
10:51AM  
10:43AM  
08:00AM  
Nov-05-20 07:40PM  
04:05PM  
03:15PM  
11:38AM  
08:58AM  
Nov-04-20 09:52AM  
Nov-03-20 10:29AM  
10:26AM  
10:14AM  
09:36AM  
Nov-02-20 12:46PM  
11:06AM  
Oct-30-20 03:54PM  
Oct-29-20 05:45PM  
02:25PM  
12:34PM  
11:24AM  
Oct-28-20 10:32AM  
Oct-23-20 05:45PM  
Oct-21-20 11:30AM  
10:48AM  
Oct-20-20 10:26AM  
Oct-19-20 10:09AM  
10:05AM  
09:55AM  
Oct-16-20 09:58AM  
08:54AM  
Oct-15-20 05:45PM  
12:45PM  
10:24AM  
Oct-14-20 10:03AM  
Oct-13-20 12:31PM  
10:36AM  
10:32AM  
10:30AM  
09:47AM  
09:45AM  
08:30AM  
Oct-12-20 09:45AM  
08:50AM  
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4/7. Further, the company offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, it offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies/non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kramer RobertPresident and CEOFeb 08Option Exercise30.7945,3971,397,961171,607Feb 09 05:23 PM
Kramer RobertPresident and CEOFeb 08Sale120.0345,3975,449,002139,210Feb 09 05:23 PM
Kramer RobertPresident and CEOJan 21Option Exercise26.4521,900579,255161,110Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 21Sale110.0321,9002,409,657139,210Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 20Option Exercise26.452,23259,036141,442Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 20Sale110.002,232245,520139,210Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 15Option Exercise25.6219,026487,446158,236Jan 19 04:28 PM
Kramer RobertPresident and CEOJan 15Sale106.0119,0262,016,901139,210Jan 19 04:28 PM
El-Hibri FuadChairmanNov 10Option Exercise26.4519,391512,8921,143,379Nov 12 06:30 PM
El-Hibri FuadChairmanNov 10Sale88.2119,3911,710,4801,123,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 09Option Exercise26.4520,000529,0001,143,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 09Sale95.2620,0001,905,2001,123,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 03Option Exercise26.4520,000529,0001,143,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 03Sale90.7420,0001,814,8001,123,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 02Option Exercise26.4520,000529,0001,143,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 02Sale90.4420,0001,808,8001,123,988Nov 04 08:53 PM
El-Hibri FuadChairmanSep 24Sale98.8512,5351,239,0851,123,988Sep 25 07:00 PM
El-Hibri FuadChairmanSep 23Sale100.5813,0001,307,5401,136,523Sep 25 07:00 PM
El-Hibri FuadChairmanSep 17Sale100.6820,0002,013,6001,149,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 16Sale102.4820,0002,049,6001,169,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 10Sale102.6620,0002,053,2001,189,523Sep 11 09:21 PM
El-Hibri FuadChairmanSep 09Sale102.8020,0002,056,0001,209,523Sep 11 09:21 PM
SULLIVAN LOUIS WDirectorSep 02Option Exercise20.087,893158,49150,655Sep 04 08:08 PM
SULLIVAN LOUIS WDirectorSep 02Sale111.2228,4183,160,60642,762Sep 04 08:08 PM
Bailey SueDirectorAug 18Sale128.314,665598,56432,595Aug 19 05:08 PM
Harsanyi ZsoltDirectorAug 17Sale133.716,609883,66424,579Aug 18 09:12 AM
JOULWAN GEORGE ADirectorAug 11Sale124.116,000744,63526,771Aug 12 04:52 PM
Zoon Kathryn CDirectorAug 10Sale130.271,000130,27012,489Aug 11 04:43 PM
Richard RonaldDirectorAug 07Sale131.006,297824,9078,276Aug 11 04:46 PM
Richard RonaldDirectorJun 03Sale87.516,572575,1424,269Jun 05 04:36 PM
Bailey SueDirectorJun 03Sale87.505,322465,69137,260Jun 05 04:33 PM
Hauer Jerome MDirectorMay 26Sale85.154,385373,37310,188May 27 05:10 PM
Zoon Kathryn CDirectorMay 26Sale85.104,093348,32213,489May 27 05:07 PM
Harsanyi ZsoltDirectorMay 14Option Exercise18.643,43464,01028,367May 18 07:12 PM
Zoon Kathryn CDirectorMay 12Sale85.211,660141,45414,761May 14 04:30 PM
Harsanyi ZsoltDirectorMay 11Sale81.994,940405,02524,933May 13 07:47 PM
JOULWAN GEORGE ADirectorMay 11Sale85.192,000170,37129,950May 13 07:45 PM
Richard RonaldDirectorMay 05Sale80.198,375671,6298,020May 06 05:08 PM
El-Hibri FuadChairmanApr 30Sale74.0120,0001,480,2001,229,523May 01 08:13 PM
El-Hibri FuadChairmanApr 29Sale74.2420,0001,484,8001,249,523May 01 08:13 PM
Richard RonaldDirectorApr 27Option Exercise20.087,893158,49124,288Apr 29 04:35 PM
Richard RonaldDirectorApr 27Sale78.007,893615,65416,395Apr 29 04:35 PM
El-Hibri FuadChairmanApr 23Sale68.4920,0001,369,8001,269,523Apr 24 04:16 PM
El-Hibri FuadChairmanApr 22Sale66.8120,0001,336,2001,289,523Apr 24 04:16 PM
Havey AdamEVP, Business OperationsApr 20Option Exercise30.8617,009524,89851,265Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 20Sale69.0017,0091,173,62134,256Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 17Option Exercise26.4520,414539,95054,670Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 17Sale65.0020,4141,326,91034,256Apr 21 06:12 PM
El-Hibri FuadChairmanApr 16Sale62.4720,0001,249,4001,309,523Apr 20 06:30 PM
El-Hibri FuadChairmanApr 15Sale62.5812,537784,5651,329,523Apr 15 09:04 PM
El-Hibri FuadChairmanApr 14Sale62.996,261394,3801,342,060Apr 15 09:04 PM
El-Hibri FuadChairmanApr 13Sale62.2517,0711,062,6701,348,321Apr 15 09:04 PM
El-Hibri FuadChairmanApr 09Sale61.8323,7161,466,3601,365,392Apr 10 07:13 PM
El-Hibri FuadChairmanApr 08Sale61.1337,3622,284,1151,389,108Apr 10 07:13 PM
El-Hibri FuadChairmanApr 07Sale60.7614,336871,0551,426,470Apr 08 09:17 PM
Kirk SeanEVP, Manufacturing & Tech OpsApr 06Option Exercise30.7010,428320,13119,864Apr 08 08:19 PM
El-Hibri FuadChairmanApr 06Sale60.5028,2401,708,5201,440,806Apr 08 09:17 PM
Havey AdamEVP, Business OperationsApr 06Sale60.007,972478,32034,256Apr 08 08:22 PM
Kirk SeanEVP, Manufacturing & Tech OpsApr 06Sale60.0016,094965,64012,571Apr 08 08:19 PM
Harsanyi ZsoltDirectorMar 16Sale65.006,400416,00029,873Mar 17 04:39 PM
SULLIVAN LOUIS WDirectorMar 04Option Exercise13.8615,786218,71568,359Mar 06 04:37 PM
Zoon Kathryn CDirectorMar 04Sale60.6599160,10316,421Mar 06 04:39 PM
SULLIVAN LOUIS WDirectorMar 04Sale58.9615,786930,71460,466Mar 06 04:37 PM
El-Hibri FuadChairmanFeb 27Sale56.979,837560,4141,469,046Feb 28 08:01 PM
Bailey SueDirectorFeb 27Sale56.936,572374,13239,761Mar 02 05:28 PM